ARCHIVES

Weight An Indicator For Risk Of Developing Myeloma

This article is from The Cancer Letter archive.

Vol. 30 No. 8 | August 31, 2007

Download PDF Visit The Full Archive

Related Articles

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

NCI selects nanotech centers for funding.

October 14, 2005

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987